10 results on '"Tavitian, Bertrand"'
Search Results
2. Development of an instrument for time–activity curve measurements during PET imaging of rodents
- Author
-
Reymond, Jean-Marc, Guez, David, Kerhoas, Sophie, Mangeot, Philippe, Boisgard, Raphaël, Jan, Sébastien, Tavitian, Bertrand, and Trebossen, Régine
- Published
- 2007
- Full Text
- View/download PDF
3. 3D-printed protected face shields for health care workers in Covid-19 pandemic.
- Author
-
Lemarteleur, Vincent, Fouquet, Vincent, Le Goff, Stéphane, Tapie, Laurent, Morenton, Pascal, Benoit, Aurélie, Vennat, Elsa, Zamansky, Bruno, Guilbert, Thomas, Depil-Duval, Arnaud, Gaultier, Anne-Laure, Tavitian, Bertrand, Plaisance, Patrick, Tharaux, Pierre-Louis, Ceccaldi, Pierre-François, Attal, Jean-Pierre, and Dursun, Elisabeth
- Abstract
• Eye-protecting devices are crucial to cut off virus transmission via conjunctiva. • 3D-printing devices inside hospital setting allows rapid and large-scale manufacture. • An ongoing dialogue in an interdisciplinary group allows iterative improvements. The coronavirus pandemic resulted in a shortage of protective equipment. To meet the request of eye-protecting devices, an interdisciplinary consortium involving practitioners, researchers, engineers and technicians developed and manufactured thousands of inexpensive 3D-printed face shields, inside hospital setting. This action leads to the concept of "concurrent, agile, and rapid engineering". [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis.
- Author
-
Schmitt, Charlotte C., Aranias, Thomas, Viel, Thomas, Chateau, Danielle, Le Gall, Maude, Waligora-Dupriet, Anne-Judith, Melchior, Chloé, Rouxel, Ophélie, Kapel, Nathalie, Gourcerol, Guillaume, Tavitian, Bertrand, Lehuen, Agnès, Brot-Laroche, Edith, Leturque, Armelle, Serradas, Patricia, and Grosfeld, Alexandra
- Abstract
Objective Intestinal glucose absorption is orchestrated by specialized glucose transporters such as SGLT1 and GLUT2. However, the role of GLUT2 in the regulation of glucose absorption remains to be fully elucidated. Methods We wanted to evaluate the role of GLUT2 on glucose absorption and glucose homeostasis after intestinal-specific deletion of GLUT2 in mice (GLUT2 ΔIEC mice). Results As anticipated, intestinal GLUT2 deletion provoked glucose malabsorption as visualized by the delay in the distribution of oral sugar in tissues. Consequences of intestinal GLUT2 deletion in GLUT2 ΔIEC mice were limiting body weight gain despite normal food intake, improving glucose tolerance, and increasing ketone body production. These features were reminiscent of calorie restriction. Other adaptations to intestinal GLUT2 deletion were reduced microvillus length and altered gut microbiota composition, which was associated with improved inflammatory status. Moreover, a reduced density of glucagon-like peptide-1 (GLP-1) positive cells was compensated by increased GLP-1 content per L-cell, suggesting a preserved enteroendocrine function in GLUT2 ΔIEC mice. Conclusions Intestinal GLUT2 modulates glucose absorption and constitutes a control step for the distribution of dietary sugar to tissues. Consequently, metabolic and gut homeostasis are improved in the absence of functional GLUT2 in the intestine, thus mimicking calorie restriction. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms.
- Author
-
Sarda-Mantel, Laure, Alsac, Jean-Marc, Boisgard, Raphaël, Hervatin, Florence, Montravers, Françoise, Tavitian, Bertrand, Michel, Jean-Baptiste, and Le Guludec, Dominique
- Subjects
POSITRON emission tomography ,LEUKOCYTE count ,ABDOMINAL aortic aneurysms ,RADIOPHARMACEUTICALS ,RADIOACTIVE tracers ,BENZODIAZEPINE antagonists - Abstract
Objective: Abdominal aortic aneurysm (AAA) is a frequent form of atherothrombotic disease, whose natural history is to enlarge and rupture. Indicators other than AAA diameter would be useful for preventive surgery decision-making, including positron-emission tomography (PET) methods permitting visualization of aortic wall leukocyte activation relevant to prognostic AAA evaluation. In this study, we compare three PET tracers of activated leukocytes, 18F-fluoro-deoxy-glucose (FDG), 18F-fluoro-methyl-choline (FCH), and 18F-DPA714 (a peripheral benzodiazepine receptor antagonist) for in vivo PET quantification of aortic wall inflammation in rat experimental AAAs, in correlation with histopathological studies of lesions. Methods: AAAs were induced by orthotopic implantation of decellularized guinea pig abdominal aorta in 46 Lewis rats. FDG-PET (n = 20), FCH-PET (n = 8), or both (n = 12) were performed 2 weeks to 4 months after the graft, 1 hour after tracer injection (30 MBq). Six rats (one of which had FDG-PET) underwent 18F-DPA714-PET. Rats were sacrificed after imaging; AAAs and normal thoracic aortas were cut into axial sections for quantitative autoradiography and histologic studies, including ED1 (macrophages) and CD8 T lymphocyte immunostaining. Ex vivo staining of AAAs and thoracic aortas with 18F-DPA714 and unlabeled competitors was performed. Results: AAAs developed in 35 out of 46 cases. FCH uptake in AAAs was lower than that of FDG in all cases on imaging, with lower AAA-to-background maximal standardized uptake value (SUV
max ) ratios (1.78 ± 0.40 vs 2.71 ± 0.54; P < .01 for SUVmax ratios), and lower AAA-to-normal aorta activity ratios on autoradiography (3.52 ± 1.26 vs 8.55 ± 4.23; P < .005). FDG AAA-to-background SUVmax ratios correlated with the intensity of CD8 + ED1 staining (r = .76; P < .03). FCH AAA-to-background SUVmax ratios correlated with the intensity of ED1 staining (r = .80; P < .03). 18F-DPA714 uptake was similar in AAAs and in normal aortas, both in vivo and ex vivo. Conclusions: In rat experimental AAA, characterized by an important aortic wall leukocytes activity, FDG-PET showed higher sensitivity than FCH-PET and 18F-DPA714-PET to detect activated leukocytes. This enhances potential interest of this tracer for prognostic evaluation of AAA in patients. [Copyright &y& Elsevier]- Published
- 2012
- Full Text
- View/download PDF
6. Sodium Iodide Symporter Is Expressed at the Preneoplastic Stages of Liver Carcinogenesis and in Human Cholangiocarcinoma.
- Author
-
Liu, Bingkai, Hervé, Julie, Bioulac–Sage, Paulette, Valogne, Yannick, Roux, Jérôme, Yilmaz, Funda, Boisgard, Raphaël, Guettier, Catherine, Calès, Paul, Tavitian, Bertrand, Samuel, Didier, Clerc, Jérôme, Bréchot, Christian, and Faivre, Jamila
- Subjects
SODIUM iodide ,LIVER cancer ,CHOLANGIOCARCINOMA ,CARCINOGENESIS - Abstract
Background & Aims: The ability of thyroid cells to take up iodide, which enables
131 I radiotherapy for thyroid cancer, is due to the expression of the sodium iodide symporter at their plasma membrane. Expression of this symporter has been found in some nonthyroid cancers. However, it is mostly accumulated in the cytoplasm, and its functionality has not been demonstrated. We have investigated sodium iodide symporter expression and functionality in human liver cancer, and in a diethylnitrosamine induced Wistar rat model of primary liver cancer at different stages of carcinogenesis. Methods: Sodium iodide symporter mRNA and protein were studied in tissues from patients with hepatocellular- or cholangio-carcinomas using reverse-transcription polymerase chain reaction, immunoblot, and immunohistochemistry. We studied the dynamics of hepatic iodine uptake in the animal model using nuclear imaging. Results: Sodium iodide symporter expression showed up in all 20 cholangiocarcinomas, but in only 2 of the 26 hepatocellular carcinomas, investigated. It was also found in normal bile duct cells and in the ductular reaction present in cirrhotic tissues. It was located at the plasma membrane in 10 of 20 cholangiocarcinoma. In rat liver cancer, a functional sodium iodide symporter expression was triggered as from the early preneoplastic steps, and was amplified during clonal tumor cell expansion, allowing complete tumor suppression after131 I radiotherapy. Conclusions: A significant proportion of human cholangiocarcinomas expresses membrane sodium iodide symporter, which may permit radioiodine therapy. Our data also suggest that131 I acts on a crucial target for liver cancer development. [Copyright &y& Elsevier]- Published
- 2007
- Full Text
- View/download PDF
7. Positron emission tomography study of [ 11C]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain
- Author
-
Tavitian, Bertrand, Pappata, Sabina, Bonnot-Lours, Sophie, Prenant, Christian, Jobert, Antoinette, Crouzel, Christian, and Di Giamberardino, Luigi
- Published
- 1993
- Full Text
- View/download PDF
8. In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
- Author
-
Vicidomini, Caterina, Panico, Mariarosaria, Greco, Adelaide, Gargiulo, Sara, Coda, Anna Rita Daniela, Zannetti, Antonella, Gramanzini, Matteo, Roviello, Giovanni N., Quarantelli, Mario, Alfano, Bruno, Tavitian, Bertrand, Dollé, Frederic, Salvatore, Marco, Brunetti, Arturo, and Pappatà, Sabina
- Subjects
- *
DIAGNOSTIC imaging , *TRANSLOCATOR proteins , *LIGANDS (Biochemistry) , *LABORATORY mice , *BRAIN physiology , *TISSUE physiology , *POSITRON emission tomography , *ENCEPHALITIS diagnosis - Abstract
Introduction The translocator protein 18 kDa (TSPO), a biochemical marker of neuroinflammation, is highly expressed in the brain activated microglia and it is also expressed by peripheral inflammatory cells and normal peripheral tissues. Thus, development of radioligands for the TSPO may contribute to further understanding the in vivo TSPO function in central and peripheral inflammatory processes and other pathologies. Here, we report the biodistribution, the specific binding and the radiometabolites of [ 18 F]DPA-714, a promising fluorinated PET radiotracer, in normal mice using a microPET/CT scanner. Methods The in vivo biodistribution and kinetics of [ 18 F]DPA-714 were measured in mice brain and peripheral tissues. Specific binding to TSPO sites was assessed using pharmacological competitive studies by means of saturation experiments performed by i.v. injection of 1 mg/kg of unlabeled DPA-714 or 3 mg/kg of unlabeled PK11195. A region of interest analysis was performed to generate time-activity curves in the brain, heart, lung, kidney, spleen and liver. Metabolites assay was performed in the plasma and peripheral organs by radio-HPLC. Results [ 18 F]DPA-714 reached high concentration in lung, heart, kidney and spleen, tissues well known to be rich in TSPO sites. [ 18 F]DPA-714 kinetics were faster in the lung and slower in the kidney. Pre-injection of unlabeled DPA-714 or PK11195 inhibited about 80% of [ 18 F]DPA-714 uptake in the lung and heart (p < 0.0005). The percentage of inhibition in the kidney was lower and achieved at later times only with DPA-714 (p < 0.05) but not with PK11195. Sixty minutes after radiotracer injection only unmetabolized radioligand was found in the brain, lung, heart and spleen. Conclusion These results suggest that [ 18 F]DPA-714 is a suitable PET ligand for imaging in mice brain and peripheral tissues since it binds with high specificity TSPO binding sites and it is almost unchanged at 60 minutes after radiotracer injection in the brain and TSPO-rich regions. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Synthesis of 6-[18F]fluoro-PBR28, a novel radiotracer for imaging the TSPO 18kDa with PET
- Author
-
Damont, Annelaure, Boisgard, Raphaël, Kuhnast, Bertrand, Lemée, Frédéric, Raggiri, Guillaume, Scarf, Alana M., Da Pozzo, Eleonora, Selleri, Silvia, Martini, Claudia, Tavitian, Bertrand, Kassiou, Michael, and Dollé, Frédéric
- Subjects
- *
RADIOACTIVE tracers , *POSITRON emission tomography , *MEDICAL imaging systems , *POLYETHYLENE terephthalate , *ACETAMIDE , *NEUROLOGICAL disorders , *HIGH performance liquid chromatography , *FLUORINE isotopes - Abstract
Abstract: 6-Fluoro-PBR28 (N-(6-fluoro-4-phenoxypyridin-3-yl)-N-(2-methoxybenzyl)acetamide), a fluorinated analogue of the recently developed TSPO 18kDa ligand PBR28, was synthesized and labelled with fluorine-18. 6-Fluoro-PBR28 and its 6-chloro/6-bromo counterparts were synthesized in six chemical steps and obtained in 16%, 10% and 19% overall yields, respectively. Labelling with fluorine-18 was performed in one single step (chlorine/bromine-for-fluorine heteroaromatic substitution) using a Zymate-XP robotic system affording HPLC-purified, ready-to-inject, 6-[18F]fluoro-PBR28 (>95% radiochemically pure). Non-decay-corrected overall yields were 9–10% and specific radioactivities ranged from 74 to 148GBq/μmol. In vitro binding experiments, dynamic μPET studies performed in a rat model of acute neuroinflammation (unilaterally, AMPA-induced, striatum-lesioned rats) and ex vivo autoradiography on the same model demonstrated the potential of 6-[18F]fluoro-PBR28 to image the TSPO 18kDa using PET. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
10. Binding of an aptamer to the N-terminal fragment of VCAM-1
- Author
-
Chauveau, Fabien, Aissouni, Youssef, Hamm, Jorg, Boutin, Hervé, Libri, Domenico, Ducongé, Frédéric, and Tavitian, Bertrand
- Subjects
- *
OLIGONUCLEOTIDES , *NUCLEOTIDES , *NUCLEIC acids , *BIOMOLECULES - Abstract
Abstract: In vitro selection of 2′-fluoropyrimidine oligonucleotide aptamers was performed against the N-terminal two-domain fragment of mouse VCAM-1. The SELEX procedure enriched the starting pool in a family of homologous sequences. High binding affinity (10nM) of one member of this family, aptamer 12.11, was demonstrated in a filter binding assay. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.